UCSF

Tagged: Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG)

Psychiatric Cell Map Initiative Symposium

About the event

QBI Hackathon

The QBI Hackathon is a 48-hour event connecting the vibrant Bay Area developer community with the scientists from UCSF, during which we work together on the cutting-edge biomedical problems. Recent advances in computer vision, AI, and machine learning have enabled computers to identify cat videos,...

Stronger There, Safer Here: A Photo Exhibition Opening Reception

The Quantitative Biosciences Institute at UCSF, in collaboration with the Institute of Global Health at UCSF, presents the opening reception for the United States Agency for International Development (USAID) Photographic Exhibition “Stronger There, Safer Here.”

2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

QBI pioneers a collaborative and inclusive approach to scientific discovery

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

The dean advocates for medication lists and pharmacist engagement in patient care

Medical errors are the third leading cause of death in the U.S., trailing cancer and heart disease. Many of those errors can be traced to issues with medications.

Stopping cancer in its tracks

Cancer, fundamentally, is a problem of too much growth. For decades, health care providers have tried and failed to slow tumor growth using drugs that interfere with a particular signaling pathway, called PI3K, which is known to operate in proliferating cancer cells.

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Sali elected to National Academy of Sciences

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

Behind enemy lines

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

Pages